Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial - de Boer, S M; Powell, M E; Mileshkin, L (Lancet Oncol, 2016)